Case Report
Jockey horse trainer

Nicholas is a 38-year-old retired jockey who attends regularly for prescriptions for timolol and latanoprost eye drops to control his longstanding glaucoma.

Today he presents complaining of

Dr David Bossingham27th February 2019

With or without existing kidney disease, kidney function is more likely to decline over time the more severely obese a person is, a large study suggests.

Compared with adults who are merely

Patients with moderate to severe chronic kidney disease may be at increased risk of developing aortic stenosis, according to results from the Swedish SCREAM project.

Previous studies have shown that

Lots of little oddities show up incidentally when scanning patients, but this one really takes the cake.

When an 18-year-old man presented to an ED in New Delhi, India, with symptoms of an abdominal

Patients with familial hypercholesterolemia (FH) are at increased risk of peripheral arterial disease and chronic kidney disease, a prospective study confirms.

Ankle-brachial index and eGFR are also

Rivaroxaban has a favourable safety in real-world practice, according to a large prospective study.

More than 11,000 patients with AF from 47 countries prescribed rivaroxaban (Xarelto) for stroke

Sponsored This content was developed by Australian Doctor Group with an independent grant from Nutricia. To update your skills in managing infantile colic and constipation, click here to access…
27th February 2019

A 37-year-old woman presents to her GP with recurring abdominal and flank pain. 

She mentions her mother had kidney problems but she doesn’t know many details. 

Examination reveals a blood pressure

Read this How to Treat article and take the quiz to earn 2 RACGP QI&CPD points or 1 ACRRM point.

Read this How to Treat article and take the quiz to earn 2 RACGP QI&CPD points or 1 ACRRM point.

It is safe to slowly escalate allopurinol levels beyond the creatinine clearance-based dose in patients with gout, two-year results from a New Zealand study have confirmed.

This follows a report on

Renal damage from prolonged use of proton-pump inhibitors (PPIs) can be silent and deadly, research shows.The evaluation of US veterans’ databases of outcomes for 125,000 patients, who were new users